Nice try Pillman. I can see from the NWE thread that your the chief commentator there, talking it up big time. I don't know if anyone thinks DLS is an 'exit' for this week. This is a poor week to go selling out.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%